Antibody response

Prospective Evaluation of Antibody Response post COVID-19 vaccination in older persons ≧ 60 years old (PEARL 60): A longitudinal 15-months study in a tertiary centre in Malaysia

Kejal Hasmukharay, Ashutosh Kumar Verma, Kiirtaara Aravindhan, Prakhaash Raaj S. Alagappan, Aisya Karynna Md Kamal, Nurul Syuhada Zulhaimi, Nor Izzati Saedon, Jamal I-Ching-Sam, Tan Maw Pin, Reena Rajasuriar

published 10 Feb 2026

Loading metrics information...

Metrics unavailable. Please check back later.

Malaria-diabetes comorbidity is linked to higher parasitaemia and enhanced IgG response to malaria vaccine candidate antigens

Gideon Agyare, David Courtin, Samuel Asamoah Sakyi, Gideon Kwesi Nakotey, Naa Adjeley Frempong, Prince Amoah Barnie, Samuel Kofi Tchum, Samuel Victor Nuvor, Benjamin Amoani

published 06 Feb 2026

Loading metrics information...

Metrics unavailable. Please check back later.

Symptom burden, viral load, and antibody response to ancestral SARS-CoV-2 strain [D614G] in an outpatient household cohort

Mehal Churiwal, Kathleen Tompkins, Gabrielle Streeter, Christy Litel, Sydney Mason, Kelly Lin, Meredith Muller, Srijana Chhetri, Tia Belvin, Feng-Chang Lin, Christopher Basham, Maureen Whittelsey, Tyler Rapp, Lakshmanane Premkumar, Carla Cerami, Jessica T. Lin

published 05 Feb 2026

Loading metrics information...

Metrics unavailable. Please check back later.

Pulmonary function and comparative SARS-CoV-2 RBD-specific IgG antibody response among the COVID-19 recovered group

Abu Bakar Siddik, Arman Faisal, Abdullah-Hel-Kafi khan, Md. Meer Mahbubul Alam, Jannatul Nayeem, Umme Kulsum, Sharmin Aktar Mukta, Zannat Kawser, Imrul Hasan, Kasrina Azad, Moajjam Hossain, Sanchita Kar, Nishat Sultana, Md Rabiul Alam, Ahmed Mustafa, Mohammad Tanbir Habib, Edward T. Ryan, Firdausi Qadri, Mohammad Rashidul Hassan

published 11 Jul 2025

Loading metrics information...

Metrics unavailable. Please check back later.

A longitudinal assessment of the antibody response to SARS-CoV-2 infection in the New Mexican population

Frances M. Twohig, Tonilynn M. Baranowski, Chunyan Ye, Michelle Harkins, Steven B. Bradfute

published 08 Jul 2025

Loading metrics information...

Metrics unavailable. Please check back later.

Long-term anti-SARS-CoV-2 antibody trajectories after neutralizing monoclonal antibody treatment

Elizabeth S. Munroe, Greg A. Grandits, Robert C. Hyzy, Hallie C. Prescott, Thomas W. Barrett, Robin L. Dewar, Nicole Engen, Anna L. Goodman, Timothy J. Hatlen, Helene Highbarger, Thomas L. Holland, Gareth Hughes, Tomas O. Jensen, Muhammad A. Khan, Ioannis Kalomenidis, Nayon Kang, Sylvain Laverdure, Prasad Manian, Vidya Menon, Ravi Patel, Srikanth Ramachandruni, Tauseef Rehman, Kathryn Shaw-Saliba, Birgit Thorup Røge, David M. Vock, Amy C. Weintrob, Barnaby E. Young, Anne P. Frosch, for the STRIVE Network and Therapeutics for Inpatients with COVID-19 (TICO) study groups

published 18 Jun 2025

Loading metrics information...

Metrics unavailable. Please check back later.

Differential immunogenicity in people living with HIV with varying CD4 levels after bivalent mRNA COVID-19 booster vaccination

Napon Hiranburana, Nattakarn Thippamom, Anchalee Avihingsanon, Supaporn Wacharapluesadee, Sasiwimol Ubolyam, Stephen J. Kerr, Chee Wah Tan, Lin-Fa Wang, Opass Putcharoen

published 29 Apr 2025

Loading metrics information...

Metrics unavailable. Please check back later.

Impact of memory T cells on SARS-CoV-2 vaccine response in hematopoietic stem cell transplant

Jennifer VanOudenhove, Yuxin Liu, Raman Nelakanti, Dongjoo Kim, Emma Busarello, Natalia Tijaro Ovalle, Zhihong Qi, Padmavathi Mamillapalli, Alexa Siddon, Zhiliang Bai, Alfredo Axtmayer, Cheryl Corso, Shalin Kothari, Francine Foss, Iris Isufi, Toma Tebaldi, Lohith Gowda, Rong Fan, Stuart Seropian, Stephanie Halene

published 28 Apr 2025

Loading metrics information...

Metrics unavailable. Please check back later.

Cross-reactivity of rPvs48/45, a recombinant Plasmodium vivax protein, with plasma from Plasmodium falciparum endemic areas of Africa

Saidou Balam, Kazutoyo Miura, Imen Ayadi, Drissa Konaté, Nathan C. Incandela, Valentina Agnolon, Merepen A. Guindo, Seidina A. S. Diakité, Sope Olugbile, Issa Nebie, Sonia M. Herrera, Carole Long, Andrey V. Kajava, Mahamadou Diakité, Giampietro Corradin, Socrates Herrera, Myriam Arevalo Herrera

published 18 Mar 2025

Loading metrics information...

Metrics unavailable. Please check back later.

Antibody response to Plasmodium vivax in the context of Epstein-Barr virus (EBV) co-infection: A 14-year follow-up study in the Amazon rainforest

Luiz F. F. Guimarães, Bárbara A. Rodrigues, Michelle H. F. Dias, Matheus G. Barcelos, Maria F. A. Nascimento, Sâmick L. Moreira-Nascimento, Sofia L. Afonso, Barbara G. S. Abreu, Jaap M. Middeldorp, Francis B. Ntumngia, John H. Adams, Camila Fabbri, Stefanie Lopes, Cor J. F. Fernandes, Flora S. Kano, Luzia H. Carvalho

published 29 Jan 2025

Loading metrics information...

Metrics unavailable. Please check back later.

Characterization of human exposure to Anopheles and Aedes bites using antibody-based biomarkers in rural zone of Cameroon

Idriss Nasser Ngangue-Siewe, Paulette Ndjeunia-Mbiakop, André Barembaye Sagna, Abdoul-Aziz Mamadou Maïga, Roland Bamou, Antoine Sanon, Jeannette Tombi, Jean Arthur Mbida Mbida, Christophe Antonio-Nkondjio, Franck Remoue, Athanase Badolo

published 05 Dec 2024

Loading metrics information...

Metrics unavailable. Please check back later.

Predictive immunoinformatics reveal promising safety and anti-onchocerciasis protective immune response profiles to vaccine candidates (Ov-RAL-2 and Ov-103) in anticipation of phase I clinical trials

Derrick Neba Nebangwa, Robert Adamu Shey, Daniel Madulu Shadrack, Cabirou Mounchili Shintouo, Ntang Emmaculate Yaah, Bernis Neneyoh Yengo, Mary Teke Efeti, Ketura Yaje Gwei, Darling Bih Aubierge Fomekong, Gordon Takop Nchanji, Arnaud Azonpi Lemoge, Fidele Ntie‑Kang, Stephen Mbigha Ghogomu

published 21 Oct 2024

Loading metrics information...

Metrics unavailable. Please check back later.

Identification of antibody targets associated with lower HIV viral load and viremic control

Wendy Grant-McAuley, William R. Morgenlander, Ingo Ruczinski, Kai Kammers, Oliver Laeyendecker, Sarah E. Hudelson, Manjusha Thakar, Estelle Piwowar-Manning, William Clarke, Autumn Breaud, Helen Ayles, Peter Bock, Ayana Moore, Barry Kosloff, Kwame Shanaube, Sue-Ann Meehan, Anneen van Deventer, Sarah Fidler, Richard Hayes, H. Benjamin Larman, Susan H. Eshleman, for the HPTN 071 (PopART) Study Team

published 17 Sep 2024

Loading metrics information...

Metrics unavailable. Please check back later.

Antibody response

Prospective Evaluation of Antibody Response post COVID-19 vaccination in older persons ≧ 60 years old (PEARL 60): A longitudinal 15-months study in a tertiary centre in Malaysia

Malaria-diabetes comorbidity is linked to higher parasitaemia and enhanced IgG response to malaria vaccine candidate antigens

Symptom burden, viral load, and antibody response to ancestral SARS-CoV-2 strain [D614G] in an outpatient household cohort

Pulmonary function and comparative SARS-CoV-2 RBD-specific IgG antibody response among the COVID-19 recovered group

A longitudinal assessment of the antibody response to SARS-CoV-2 infection in the New Mexican population

Long-term anti-SARS-CoV-2 antibody trajectories after neutralizing monoclonal antibody treatment

Differential immunogenicity in people living with HIV with varying CD4 levels after bivalent mRNA COVID-19 booster vaccination

Impact of memory T cells on SARS-CoV-2 vaccine response in hematopoietic stem cell transplant

Cross-reactivity of rPvs48/45, a recombinant Plasmodium vivax protein, with plasma from Plasmodium falciparum endemic areas of Africa

Antibody response to Plasmodium vivax in the context of Epstein-Barr virus (EBV) co-infection: A 14-year follow-up study in the Amazon rainforest

Characterization of human exposure to Anopheles and Aedes bites using antibody-based biomarkers in rural zone of Cameroon

Predictive immunoinformatics reveal promising safety and anti-onchocerciasis protective immune response profiles to vaccine candidates (Ov-RAL-2 and Ov-103) in anticipation of phase I clinical trials

Identification of antibody targets associated with lower HIV viral load and viremic control

Antibody response

Connect with Us